Lisata Therapeutics, Inc. (LSTA)
1.935
+0.08
(+4.03%)
USD |
NASDAQ |
Sep 09, 12:39
Lisata Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.0022 |
| March 31, 2025 | 0.0036 |
| December 31, 2024 | 0.0046 |
| September 30, 2024 | 0.0054 |
| June 30, 2024 | 0.0058 |
| March 31, 2024 | 0.0061 |
| December 31, 2023 | 0.0063 |
| September 30, 2023 | 0.0065 |
| June 30, 2023 | 0.0066 |
| March 31, 2023 | 0.0069 |
| December 31, 2022 | 0.0073 |
| September 30, 2022 | 0.0076 |
| June 30, 2022 | 0.0068 |
| March 31, 2022 | 0.0071 |
| December 31, 2021 | 0.0077 |
| September 30, 2021 | 0.0035 |
| June 30, 2021 | 0.0042 |
| March 31, 2021 | 0.0049 |
| December 31, 2020 | 0.0192 |
| September 30, 2020 | 0.0188 |
| June 30, 2020 | 0.0235 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0507 |
| December 31, 2019 | 0.047 |
| September 30, 2019 | 0.0427 |
| June 30, 2019 | 0.0128 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.0005 |
| March 31, 2018 | 0.002 |
| December 31, 2017 | 0.0032 |
| September 30, 2017 | 0.0067 |
| June 30, 2017 | 0.0193 |
| March 31, 2017 | -7.743 |
| December 31, 2016 | 0.2625 |
| September 30, 2016 | 0.6162 |
| June 30, 2016 | 1.650 |
| March 31, 2016 | 0.3164 |
| December 31, 2015 | 0.7074 |
| September 30, 2015 | 0.3036 |
| June 30, 2015 | 0.2582 |
| March 31, 2015 | 0.3318 |
| December 31, 2014 | 0.2844 |
| September 30, 2014 | 0.2691 |
| June 30, 2014 | 0.0633 |
| March 31, 2014 | 0.082 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.03M |
| Total Liabilities (Quarterly) | 3.037M |
| Shareholders Equity (Quarterly) | 8.244M |
| Current Ratio | 3.687 |
| Net Debt Paydown Yield | 0.06% |